Literature DB >> 28325436

von Willebrand factor proteolysis by ADAMTS-13 in patients on left ventricular assist device support.

Angelo Nascimbene1, Tristan Hilton2, Barbara A Konkle3, Joel L Moake4, O H Frazier5, Jing-Fei Dong3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28325436      PMCID： PMC5944844          DOI： 10.1016/j.healun.2017.01.010

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  5 in total

1.  Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device.

Authors:  George V Letsou; Nyma Shah; Igor D Gregoric; Timothy J Myers; Reynolds Delgado; O H Frazier
Journal:  J Heart Lung Transplant       Date:  2005-01       Impact factor: 10.247

2.  Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients.

Authors:  Sheri Crow; Dong Chen; Carmelo Milano; William Thomas; Lyle Joyce; Valentino Piacentino; Riti Sharma; Jogin Wu; Gowthami Arepally; Dawn Bowles; Joseph Rogers; Nestor Villamizar-Ortiz
Journal:  Ann Thorac Surg       Date:  2010-10       Impact factor: 4.330

3.  Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device.

Authors:  Anna L Meyer; Doris Malehsa; Ulrich Budde; Christoph Bara; Axel Haverich; Martin Strueber
Journal:  JACC Heart Fail       Date:  2014-04       Impact factor: 12.035

Review 4.  Acquired von Willebrand syndrome associated with left ventricular assist device.

Authors:  Angelo Nascimbene; Sriram Neelamegham; O H Frazier; Joel L Moake; Jing-Fei Dong
Journal:  Blood       Date:  2016-05-03       Impact factor: 22.113

5.  Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin.

Authors:  J L Moake; N A Turner; N A Stathopoulos; L Nolasco; J D Hellums
Journal:  Blood       Date:  1988-05       Impact factor: 22.113
  5 in total
  5 in total

1.  Quantification of Von Willebrand Factor Cleavage by adamts-13 in Patients Supported by Left Ventricular Assist Devices.

Authors:  Yong Zhou; Shizhen Qin; Tristan Hilton; Li Tang; Miguel Cruz; Ruben Hernandez; Joel L Moake; Qiang Tian; O H Frazier; Jing-Fei Dong; Angelo Nascimbene
Journal:  ASAIO J       Date:  2017 Nov/Dec       Impact factor: 2.872

2.  Benchtop von Willebrand Factor Testing: Comparison of Commercially Available Ventricular Assist Devices and Evaluation of Variables for a Standardized Test Method.

Authors:  Phillip A Coghill; Suren Kanchi; Zheila J Azartash-Namin; James W Long; Trevor A Snyder
Journal:  ASAIO J       Date:  2019-07       Impact factor: 2.872

3.  von Willebrand factor enhances microvesicle-induced vascular leakage and coagulopathy in mice with traumatic brain injury.

Authors:  Yingang Wu; Wei Liu; Yuan Zhou; Tristan Hilton; Zilong Zhao; Wei Liu; Min Wang; Jason Yeon; Katie Houck; Perumal Thiagarajan; Fangyi Zhang; Fu-Dong Shi; Xiaoping Wu; Min Li; Jing-Fei Dong; Jianning Zhang
Journal:  Blood       Date:  2018-06-25       Impact factor: 25.476

4.  A Flow Induced Autoimmune Response and Accelerated Senescence of Red Blood Cells in Cardiovascular Devices.

Authors:  James P Buerck; Dustin K Burke; David W Schmidtke; Trevor A Snyder; Dimitrios Papavassiliou; Edgar A O'Rear
Journal:  Sci Rep       Date:  2019-12-19       Impact factor: 4.379

5.  Hyperadhesive von Willebrand Factor Promotes Extracellular Vesicle-Induced Angiogenesis: Implication for LVAD-Induced Bleeding.

Authors:  Mengchen Yang; Katie L Houck; Xinlong Dong; Maria Hernandez; Yi Wang; Sriram S Nathan; Xiaoping Wu; Vahid Afshar-Kharghan; Xiaoyun Fu; Miguel A Cruz; Jianning Zhang; Angelo Nascimbene; Jing-Fei Dong
Journal:  JACC Basic Transl Sci       Date:  2022-03-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.